Prostate Brachytherapy Firms Get OPPS Victory, But Still Seek Legislative Fix
This article was originally published in The Gray Sheet
Executive Summary
Payment for prostate brachytherapy sources will be unbundled under the 2004 hospital OPPS rule - a policy shift long sought by the Coalition for the Advancement of Brachytherapy
You may also be interested in...
APC Panel Meeting News In Brief
High-dose rate brachytherapy: CMS should evaluate ways to improve data methodology for APC 313 (high-dose rate brachytherapy) for the 2005 hospital outpatient prospective payment system update, the Advisory Panel on Ambulatory Patient Classification Groups suggests Feb. 19 in Baltimore. Stakeholders contend that the claims used to set the 2004 rates are flawed, since none of the 27 single-claims used listed the source and related needle and catheter costs - criteria designating a correctly coded claim (1"The Gray Sheet" Nov. 10, 2003, p. 6). CMS says it will attempt to use more multiple claims in time for the 2005 update...
APC Panel Meeting News In Brief
High-dose rate brachytherapy: CMS should evaluate ways to improve data methodology for APC 313 (high-dose rate brachytherapy) for the 2005 hospital outpatient prospective payment system update, the Advisory Panel on Ambulatory Patient Classification Groups suggests Feb. 19 in Baltimore. Stakeholders contend that the claims used to set the 2004 rates are flawed, since none of the 27 single-claims used listed the source and related needle and catheter costs - criteria designating a correctly coded claim (1"The Gray Sheet" Nov. 10, 2003, p. 6). CMS says it will attempt to use more multiple claims in time for the 2005 update...
APC Panel Advises CMS To Review Brachytherapy Proposed Payment Rates
High-dose-rate brachytherapy manufacturers Nucletron and Varian plan to survey all 600 U.S. hospitals performing the procedure in an attempt to convince CMS to raise the 2004 proposed payment rate under the hospital outpatient prospective payment system